Osteoarthritis (OA) is the most common form of arthritis disorders, but the identification of therapeutic targets to effectively prevent OA has been increasingly difficult. The goal of this investigation is to provide experimental evidence that discoidin domain receptor 2 (DDR2) may be an ideal target for the development of disease-modifying OA drugs. Ddr2 was conditionally deleted from articular cartilage of adult mouse knee joints. Aggrecan-CreERT2;floxed Ddr2 mice, which were generated by crossing Aggrecan-CreERT2 mice with floxed Ddr2 mice, then received tamoxifen injections at the age of 8 weeks. The mice were then subjected to destabilization of the medial meniscus (DMM) surgery. At 8 and 16 weeks after DMM, mice were euthanized for the collection of knee joints. In a separate experiment, Aggrecan-CreERT2;floxed Ddr2 mice were subjected to DMM at the age of 10 weeks. The mice then received tamoxifen injections at 8 weeks after DMM. The mice were euthanized for the collection of knee joints at 16 weeks after DMM. The progressive process of articular cartilage degeneration was significantly delayed in the knee joints of Ddr2-deficient mice in comparison to their control littermates. Articular cartilage damage in the knee joints of the mice was associated with increased expression profiles of both Ddr2 and matrix metalloproteinase 13. These findings suggest that DDR2 may be an ideal target for the development of disease-modifying OA drugs. Osteoarthritis (OA) is the most common form of arthritis disorders.
Osteoarthritis (OA) is the most common form of arthritis disorders. 1 Because the molecular mechanism underlying the development of OA is largely unknown, it is difficult to identify therapeutic targets that effectively prevent and treat OA. Currently, existing drugs for the treatment of OA provide, at best, symptomatic relief from pain and inflammation. 2 Current pharmacological interventions that address chronic pain and inflammation do not prevent articular cartilage degeneration, which eventually leads to OA. Therefore, the identification of targets for the development of disease-modifying OA drugs (DMOADs) has become more pressing than ever. The objective of this present investigation is to determine whether a cell surface receptor tyrosine kinase, discoidin domain receptor 2 (DDR2), for native collagen type II is an ideal target for the development of DMOADs.
What led us to investigate the role of DDR2 in the development of OA? The answer is the classic biochemistry event in living systems, known as enzyme induction. An example of such a system is the inducible lactosemetabolizing enzyme, by which the enzyme is induced by its own substrates. Bacterial Escherichia coli is unable to directly use disaccharide lactose for consumption. However, under the condition in which lactose is solely present, the enzyme b-galactosidase is induced in E. coli. The enzyme then breaks down lactose into monosaccharides, galactose and glucose, which the bacteria is able to metabolize. We believe that the induction of matrix metalloproteinase 13 (MMP-13) in chondrocytes may represent a similar situation. For cartilage tissue turnover, extracellular matrix molecules, such as type II collagen, need to be degraded. MMP-13 can degrade type II collagen. However, type II collagen cannot enter chondrocytes to physically induce MMP-13. Thus, the collagen has to interact with a cell surface molecule(s) and send signals into chondrocytes to induce the expression of MMP-13 and the subsequent release of MMP-13 into the extracellular space. If this is the case, the question becomes which cell surface molecule(s) transduce the signal into chondrocytes? Initially, we examined whether integrin a2b1 was the cell surface receptor responsible for this transduction. 3 However, results from our previous study indicated that the blockage of the integrin a2b1 did not prevent the induction of MMP-13 in chondrocytes by native type II collagen. 4 Moreover, the activation of the integrin a2b1 and the stimulation of type II collagen to chondrocytes showed a synergistic effect on the induction of MMP-13 in the cell. This suggests that there is another cell surface receptor responsible for transducing the signal to induce MMP-13 expression. We speculated that DDR2 might be such a receptor, 5, 6 and results from our previous investigations supported our speculation. 2, 7, 8 In one of our previous investigations, we removed one copy of Ddr2 in two mouse models of OA. 9 We found that the reduction in the expression of Ddr2 attenuated articular cartilage degeneration in knee joints of the mouse models. However, several critical questions remain to be addressed before we deem DDR2 as an ideal target to develop DMOADs. First, in that study, we were unable to evaluate the chondroprotective effect of the complete removal of Ddr2 from mature articular cartilage of mouse knee joints, as a means of investigating how critical Ddr2 is to the progression of OA. This is because of the fact that homozygous conventional Ddr2 knockout mice that we used in the study exhibit short stature (dwarfism) and such cannot be used to study OA. Second, we were unable to determine whether inhibition of Ddr2, after the onset of articular cartilage degeneration, could still prevent the joint from being destroyed. This was because of the lack of a floxed Ddr2 mouse strain; therefore, a complete deletion of Ddr2 was not possible at a desirable time in articular cartilage. Third, numerous investigations report there is a biological effect secondary to the absence of DDR2 on articular cartilage development in human.
10e12 Thus, the full potential chondroprotective effect of the Ddr2 deletion by a conventional knockout technique could be compromised or misleading. To address these questions, in this present investigation, we used a conditional knockout technique to delete Ddr2 from mature articular cartilage of mouse knee joints to eliminate any potential developmental growth abnormalities that might arise. We then investigated the chondroprotective effect of the deletion of Ddr2 on knee articular cartilage before and after the onset of cartilage degeneration induced by destabilization of the medial meniscus (DMM).
In this present study, we have investigated what the potential chondroprotective effect on mouse knee joints is. To address this question, we generated a floxed Ddr2 mouse strain. We then specifically removed Ddr2 from articular chondrocytes before, or after the onset of, articular cartilage degeneration induced by DMM. We then examined the morphology of articular cartilage in knee joints of Ddr2-deficient mice and their control littermates, for evidence of changes in histology and in protein expressions of Ddr2 and Mmp-13. We also examined the expression profile of Ddr2 in normal adult mice.
Materials and Methods

Generation of the Floxed Ddr2 Mice
All animal experimental procedures were performed after approval from the Harvard Medical School Institutional Animal Care Committee. Embryonic stem cells containing the floxed Ddr2 allele were purchased from EUCOMM (Wellcome Trust Genome Campus, Hinxton, Cambridge, UK). The embryonic stem cells were injected into blastocysts with C57BL/6 genomic background to generate chimeric mice. The chimeric mice were then bred with wild-type, C57BL/6, mice to generate heterozygous floxed Ddr2 mice. The floxed Ddr2 allele contains several elements, including flippase recognition target (FRT)-flanked En2SA-IRES-LacZ-bact-Neo cassette, which may have potential effects on the development of mice. Thus, by crossing floxed Ddr2 mice with FLPeR mice, the DNA fragment containing these elements was removed, eliminating the potential for undesired developmental abnormalities.
Mouse Genotyping
Mouse genotyping for Aggrecan-CreERT2 and the floxed Ddr2 gene was performed. Genomic DNA was isolated from the mice tails. To determine whether mice were Aggrecan-CreERT2 positive (AgcCreERT2 þ/À ), the forward primer 5 0 -TAACTACCTGTTTTGCCGGG-3 0 and the reverse primer 5 0 -GTCTGCCAGGTTGGTCAGTAA-3 0 were used. The PCR for AgcCreERT2 was set for primary denaturation at 94 C for 3 minutes, followed by 30 cycles of denaturation at 94 C for 45 seconds, annealing at 60 C for 45 seconds, and elongation at 72 C for 1 minute, with final elongation at 72 C for 10 minutes. To determine whether mice were homozygous for the floxed Ddr2 gene (Ddr2 flox/flox ), the forward primer 5 0 -AGTAGGTGCTA-GCTACCTCCCACC-3 0 and the reverse primer 5 0 -CTGCT-TCCTCCCAGGTACCTTCCC-3 0 were used. The PCR for floxed Ddr2 was set for primary denaturation at 94 C for 3 minutes, followed by 30 cycles of denaturation at 94 C for 30 seconds, annealing at 60 C for 30 seconds, and elongation at 72 C for 30 seconds, with final elongation at 72 C for 10 minutes. 
;Ddr2
flox/flox mice were administered 3 mg tamoxifen per mouse at 24 hours before giving birth. The young mice were then examined at the age of 1 week old. One of the hind legs from each mouse was used for Alcian blue/alizarin red whole-mount skeleton staining. The other hind leg was embedded in paraffin section and stained with Safranin O/Fast Green for growth plate analysis. 13 Efficiency of Ddr2 Removal from Articular Chondrocytes of Mouse Knee Joints Three AgcCreERT2 þ/À ;Ddr2 flox/flox mice, at the age of 8 weeks old, were injected with tamoxifen at 2 mg/10 g body weight daily via i.p. injection for 10 consecutive days, whereas another three AgcCreERT2 þ/À ;Ddr2 flox/flox mice were injected with sunflower seed oil. The mice were then euthanized, and articular cartilage was collected from the knee joints for isolation of genomic DNA. For detection of the exon 9 of Ddr2, PCR was performed with the forward primer 5 0 -AGTAGGTGCTAGCTACCTCCCACC-3 0 and the reverse primer 5 0 -GGTTTCCATGAACCCTACTG-3 0 . For the quantitative measurement of the exon 9 of Ddr2, a duplex real-time PCR was performed using TaqMan Copy Number Assay. TaqMan probe (catalog number 4400291) for the target gene, Ddr2 exon 9 (transcript: ENSMUST00000027985), was labeled with FAM, and TaqMan probe (catalog number 4458366) for a reference gene, Tfrc, was labeled with VIC. PCR was performed in 20 mL reaction containing 20 ng of genomic DNA (Life Technologies Corporation, Carlsbad, CA), according to the company's protocol. Real-time PCR was performed at 95 C for 10 minutes, followed by 40 cycles of 95 C for 15 seconds and 60 C for 60 seconds, using StepOnePlus real-time PCR System (Thermo Fisher Scientific, Waltham, MA). Each sample was tested in triplicate.
Conditional Removal of Ddr2 in Mature Articular Cartilage of Mouse Knee Joints
The mouse strain, AgcCreERT2, expresses a recombinant protein consisting of Cre-recombinase and the modified estrogen receptor (CreERT2), driven by the endogenous aggrecan promoter. In this mouse strain, the CreERT2 is expressed in chondrocytes of uncalcified articular cartilage, but not in the chondrocytes of calcified cartilage in adult mice.
14 AgcCreERT2 þ/À mice were crossed with , were generated by crossing the double-heterozygous mutant mice and identified by PCR (see previous paragraph). AgcCreERT2 þ/À ; Ddr2 flox/flox mice, and corresponding control mice, were separated and maintained in the mouse facility under a cycle of 12-hour light and dark environments.
One group of AgcCreERT2 þ/À ;Ddr2 flox/flox mice was injected, via i.p. injection, with tamoxifen at 2 mg/10 g body weight daily for 10 consecutive days at the age of 8 weeks old. The mice were then subjected to DMM surgery. The mice were then euthanized at 8 and 16 weeks after DMM for collection of the knee joints. Another group of AgcCreERT2 þ/À ;Ddr2 flox/flox mice was subjected to DMM surgery at 10 weeks of age. These mice were then injected, via i.p. injection, with tamoxifen at 2 mg/10 g body weight daily for 10 consecutive days at 8 weeks after DMM. The mice were euthanized at 16 weeks after DMM for collection of the knee joints. The corresponding controls, DMM on AgcCreERT2 þ/À ;Ddr2 flox/flox mice without removal of Ddr2 and sham surgery on AgcCreERT2 þ/À ;Ddr2 flox/flox mice with removal of Ddr2, were also performed.
DMM surgery on mice was performed as follows. Briefly, after the mice were anesthetized via i.p. administration of ketamine (90 mg) and xylazine (10 mg)/kg mouse body weight, the right knees were prepared for aseptic surgery. The joint capsule immediately medial to the patellar tendon was opened and, for DMM, the medial meniscotibial ligament was sectioned. The joint capsule was then closed with 8-0 Vicryl suture, and the skin was closed with 7-0 suture. Sham surgery, in which the meniscotibial ligament was visualized but not transected, was performed as a negative control.
Histology and Immunohistostaining
The knee joints were fixed in 4% paraformaldehyde for 6 hours at room temperature, then decalcified in Morse's solution and processed for paraffin embedding. The samples were sectioned, by serial sectioning, at a 6 mm thickness in an anterior to posterior direction. Every tenth section was collected for Safranin O/Fast Green staining. The pathological condition of the articular cartilage was evaluated by a scoring system designed to assess the histology of OA in mouse joints; the system is recommended by the Osteoarthritis Research Society International (OARSI) histopathology initiative. 15 The minimal score of 0 is for normal mouse articular cartilage, and the maximal score of 6 is for vertical clefts/erosion to the calcified cartilage extending >75% of the articular surface.
For analysis of Ddr2 and Mmp-13 expression, 8 to 10 paraffin sections, distributed throughout each knee joint, of articular cartilage from Ddr2-deficicent and control mice at 8 weeks after the surgery, were selected for immunohistostaining. Thus, there were 32 to 40 (4 Â 8 or 4 Â 10) paraffin sections in each experiment. Paraffin sections were incubated with a polyclonal antibody against Ddr2 (1:200 dilution, catalog number sc-8989; Santa Cruz Biotechnology, Inc., Dallas, TX) or a rabbit polyclonal antibody (1 mg/mL at the final concentration of 1:400 dilution) against Mmp-13 (Abcam, Cambridge, MA). After overnight incubation at 4 C, the sections were washed and treated with a biotinylated secondary antibody. Color development was performed using a peroxidase substrate (Vector Laboratories, Burlingame, CA) after treatment of the sections with a mixture of avidin and biotinylated horseradish peroxidase (Vector Laboratories). Staining without primary antibody was performed as a negative control.
Morphological Evaluation of Articular Cartilages of
Information of the conventional Ddr2 knockout mice has been reported in our previous publication. 9 Briefly, Ddr2 is deleted by the conventional knockout technique in mice with the hybrid genetic background of C57/Black and Mouse129. For the histology study, knee joints were cut from the lateral to the medial side of the joints at 6 mm thickness by serial sectioning. The sections were stained by Safranin O/Fast Green. The pathological condition of the knee joints was evaluated by the OARSI score system.
Whole-Mount X-Gal Staining of Mouse Tissues
Multiple tissues and organs were collected from the floxed Ddr2 mice containing FRT-flanked En2SA-IRES-LacZ-bactNeo cassette (LacZ driven by endogenous Ddr2 promoter) and their control littermates at 2 and 4 months of age. Samples were subjected to whole-mount X-Gal staining. Reagents were purchased from EMD Millipore (Darmastadt, Germany), and the experimental protocol was from the company (catalog number mcproto058). Briefly, samples were fixed in tissue fixative for 45 minutes at 4 C and X-gal staining was performed at 37 C in the dark until blue color developed. The samples were then analyzed under a Leica MZ16 stereomicroscope (Leica Microsystems Inc., Buffalo Grove, IL).
Statistical Analysis
A total of 10 to 12 paraffin sections, which were evenly distributed throughout an entire joint, were examined and scored. The score from the section depicting the worst condition was selected to represent that joint. There were six to eight animals in each experimental group; therefore, six to eight scores were obtained for each group. Then, an average score was calculated from six to eight scores for each group. A Student's t-test, with a significance level of 0.05, was used to determine whether a significant difference between any two scores was present.
To determine sample size in this study, a pilot study was performed on the effect of Ddr2-deficient mice with DMM. From those results, it was concluded that a sample size with a minimum of five animals is required to achieve the specified CI (95%) with at least 50% reduction of the score in the Ddr2-deficient mice.
The t-test was also used to determine the efficiency of the Ddr2 removal and in immunohistostaining experiments.
Notation of Mouse Strains in This Study
We call the floxed Ddr2-containing FRT-flanked En2SA-IRES-LacZ-bact-Neo cassette as Ddr2-LacZ mice, the floxed Ddr2 without FRT-flanked En2SA-IRES-LacZbact-Neo cassette as Ddr2 
Results
Generation of the Floxed Ddr2 Mice
We received three Ddr2 chimeric mice. One of them contained the germline integration of the floxed Ddr2 allele. After several rounds of breeding of the chimeric mouse with wild-type C57/BL6 mice, heterozygous floxed Ddr2 mice were generated. We then removed several elements, 
Genotyping of AgcCreERT2 and Floxed Ddr2 Mice
To identify AgcCreERT2 mice, the PCR primers from the Cre-recombinase gene generated a 544-bp PCR product. Because wild-type mice do not contain the Cre-recombinase gene, there was no PCR product from genomic DNA of wild-type mice. To identify the floxed Ddr2 allele, PCR primers crossing one FRT site and one loxP site in the intron 8 of Ddr2 generated a PCR product with the size of 260 bp from genomic DNA of wild-type mice. However, these primers produced a PCR product with the size of 446 bp from genomic DNA of mice with the floxed Ddr2 allele. 
Characterization of the Floxed Ddr2 Mice
DDR2 as a Target for OA Drugs
The American Journal of Pathology -ajp.amjpathol.org (Figure 2, A and B) . Histological examination revealed the disorganized proliferating chondrocyte columns and thinner proliferative zone in the growth plate of Ddr2 D/D mice ( Figure 2C ). The phenotype of the Ddr2 D/D mice is consistent with the result from the investigation by another independent research group. 10 Efficiency of the Removal of Ddr2 in Articular Chondrocytes of the Knee Joint
We used AgcCreERT2 to remove Ddr2 specifically in articular chondrocytes of knee joints in adult mice in this experiment. Results from our previous experiment indicated that CreERT2 was highly inducible in articular chondrocytes of the knee joints in AgcCreERT2 mice at 2 months of age. 16 We noticed that the induced CreERT2 appeared in chondrocytes above the tidemark in articular cartilage, which is consistent with the result from a study by an independent research group. 14 We examined the efficiency of the ablation of Ddr2 by AgcCreERT2 in articular chondrocytes of adult mouse knee joints. After several rounds of crossing AgcCreERT2 mice with floxed Ddr2 mice, we obtained compound mutant mice, heterozygous CreERT2 driven by the endogenous aggrecan promoter and homozygous floxed Ddr2 (AgcCreERT2 þ/À ;Ddr2 flox/flox ). PCR analysis using genomic DNA from articular cartilages of the knee joints showed a 720-bp product in tamoxifen-treated (Ddr2 f/f ) mice ( Figure 3A) . We found that the exon 9 genomic DNA of Ddr2 floxed by loxP sites was deleted in 75% of articular chondrocytes in adult mouse knee joints ( Figure 3B ). The loss of the exon 9 resulted in a premature stop codon in the exon 10 of Ddr2. This result indicated that Ddr2 was deleted in most articular chondrocytes of the adult knee joints in Ddr2 D/D mice. (Figure 4, A and B) . The progression toward OA was dramatically delayed in the Ddr2 D/D mice after DMM surgery. There were no abnormal morphological changes in the sham surgery groups.
The condition of the articular cartilage was also evaluated with the scoring system designed to assess the histology of articular cartilage in a surgically induced mouse model of OA. Mice at 8 weeks after sham surgery were used as a normal control (score Z 0). At 8 weeks after DMM surgery, the average scores for Ddr2 D/D mice and Ddr2 f/f littermates were 0.64 and 1.71, respectively. At 16 weeks after DMM surgery, the average scores were 1.31 for Ddr2 D/D mice and 4.57 for Ddr2 f/f littermates. The scores were significantly different between the two groups at both time points (Table 1 ).
In addition, we noticed the appearance of osteophytes in Ddr2 f/f littermates at 16 weeks ( Figure 4C ). However, there was no evidence of osteophyte formation in Ddr2
littermates. We did not observe other abnormal morphology in the subchondral bone and synovial tissue in either Ddr2 D/D or Ddr2 f/f mice. Second, we reevaluated the pathological condition of articular cartilages of knee joints in Ddr2 þ/À mice after DMM by using the OARSI system. At 8 weeks after DMM surgery, the average scores for Ddr2 þ/À mice and Ddr2 þ/þ littermates were 0.81 and 1.88, respectively. At 16 weeks after DMM surgery, the average scores were 2.14 for Ddr2 þ/À mice and 4.63 for Ddr2 þ/þ littermates. The scores were significantly different between the two groups at both time points (Table 2) . Previously, we applied a different scoring system to the Ddr2 þ/À mice, 9 because the scoring system that we used in this present study was not available at that time. We compared the result from Ddr2 
The American Journal of Pathology -ajp.amjpathol.orgversus 1.31, but there was no significant difference between the scores at 8 weeks, scoring 0.81 versus 0.64. Third, we determined whether the deletion of Ddr2 after the initiation of cartilage degeneration could delay the progressive process of degeneration. We removed Ddr2 from the knee joints of adult mice at 8 weeks after the DMM surgery. Mice were then allowed to survive 8 additional weeks. We found significant disparities in the progressive process of cartilage degeneration in knee joints between Ddr2 D/D and Ddr2 f/f mice ( Figure 4B) ; the progression was significantly delayed in the Ddr2 D/D mice, with an average score of 1.10 (Table 1) . This is similar to what was seen in mice with DMM surgery after the deletion of Ddr2 was completed.
Immunohistostaining of Ddr2 and Mmp-13 in Articular Cartilage of Knee Joints
We examined the protein expression of Ddr2 and Mmp-13 in the articular cartilage of knee joints from mice at 8 weeks after DMM. The positive staining cells were counted in each paraffin section and summed to determine the total number of positive cells from all of the sections in each group. Ddr2 and Mmp-13 positive staining cells were detected at 4% (means AE SD Z 0.04 AE 0.02) and 5% (means AE SD Z 0.05 AE 0.02), respectively, in the articular cartilage of knee joints from Ddr2-deficient mice ( Figure 5A ). Moreover, Ddr2 and Mmp-13 positive staining cells were present at 20% (means AE SD Z 0.20 AE 0.03) and 24% (means AE SD Z 0.24 AE 0.02), respectively, in the articular cartilage of knee joints from their control littermates ( Figure 5A ). The number of positive staining cells was significantly different between the two groups (P < 0.001). The location of positive cells was randomly scattered in the superficial layer of the articular cartilage. We did not observe the increase in the expression of Ddr2 in the synovial membranes in the sham, Ddr2-deficient mice and their control littermates ( Figure 5B ).
Expression Profile of Ddr2 in Adult Mice
We investigated the expression profile of Ddr2 in adult mice using Ddr2-LacZ mice containing LacZ element driven by endogenous Ddr2 promoter. Tissues and organs expressing Ddr2 will develop blue color by whole-mount X-Gal staining. Results demonstrate that Ddr2 is not expressed broadly in adult mouse tissues. Expression was detected in the renal pelvis and testis in adult mice at 2 and 4 months of age ( Figure 6 ).
Discussion
We generated floxed Ddr2 mice. Before we used these mice for our study, we first removed several elements within the floxed Ddr2 construct from the mice to avoid any potential biological influence of those particular elements on mice development. We then characterized the mice to know whether the inserted loxP sites were accessible to the fused recombinant protein, Cre-recombinase with the modified human estrogen receptor (CreERT2). Results from our experiments demonstrated that Ddr2 D/D mice revealed a short stature (dwarfism). The growth plate of these mice showed the disorganized proliferating chondrocyte columns and a thinner growth plate. This phenotype is consistent with the gross appearance of the skeleton and the morphological alteration of the growth plate in homozygous Ddr2 knockout mice generated by the conventional knockout technique, 10 suggesting that the loxP sites in our floxed Ddr2 mice were accessible to CreERT2. By use of these mice, we were able to conditionally delete Ddr2 from articular chondrocytes of knee joints in adult mice. We found that Ddr2 was deleted/removed in 75% of articular chondrocytes and that the progressive progression of cartilage degeneration was significantly delayed by the deletion of Ddr2. This suggests that a decrease in the expression and activity of Ddr2 can decelerate the progression of cartilage degeneration, which is consistent with our previous observation. 9 Why was Ddr2 not removed completely from articular chondrocytes? There are two possible explanations. First, in our previous experiments, we found that chondrocytes below the tidemark of articular cartilage of mouse knee joints did not express aggrecan. 16 To examine the efficiency of Ddr2 removal from adult articular chondrocytes, articular cartilage was trimmed from the surface of mouse knee joints. This included chondrocytes both above and below the tidemark. However, because Cre-recombinase was under the control of the endogenous aggrecan promoter, Cre-recombinase is only expressed in aggrecanproducing cells. That may, in part, account for the 25% of cells (noneaggrecan-producing cells) in the articular cartilage that contained Ddr2. Second, it may be difficult to remove Ddr2 from every aggrecan-producing chondrocyte via tamoxifen injection.
We are aware of the report of a predisposition to the development of articular cartilage degeneration in different inbred mouse lines. 17 However, in the present study, we compared the pathological condition of articular cartilage, induced by DMM, in Ddr2 þ/À mice (the hybrid genome background of C57/Black and Mouse129) with the pathological condition in Ddr2 D/D mice (the genome background of C57/Black), and we did not observe a significant difference between these two groups. In addition, we did not see a significant difference in the predisposition to articular cartilage degeneration in mice knee joints among mice with C57/Black and Mouse129; C57/Black genome backgrounds in our other studies. 9, 16 In our previous study with Ddr2 þ/À mice, 9 we found that reduction in the expression of Ddr2 delayed the progression of articular cartilage degeneration.
In the present investigation, we used a scoring system, recommended by OARSI, to reevaluate the cartilage of knee joints from the previously mentioned study, as well as to evaluate the cartilage of knee joints in our present study. As a result, we found that a larger number of chondrocytes without Ddr2 exhibit greater chondroprotective efficiency in adult mouse knee joints. This information is critical in the consideration of Ddr2 as a target for the development of DMOADs.
Why is DDR2 a potential target for the development of DMOADs? First, on the basis of results from our studies and others' investigations, 18e20 it is clearly shown that inhibition of the activity of DDR2 can protect articular cartilage from being degraded. In the present study, we were able to delete Ddr2 before, and after the onset of, articular cartilage degeneration. Our results indicate that articular cartilage was protected under both conditions; thus, inhibition of DDR2 activity has both prophylactic and treatment effects on articular cartilage degeneration. This also implies that even individuals at high risk for the development of OA, such as athletes participating in contact sports with high injury rates, would not need to receive drugs that inhibit DDR2 activity before injury, because articular cartilage degeneration could still be delayed after the injury occurs. Hence, a small-molecule inhibitor of DDR2 can inhibit the activation of DDR2 to prevent the induction of MMP-13 against the development of OA. Second, although there is interest from pharmacological companies in inhibiting the activity of MMP-13 as a means of delaying the progression of OA, the broad biological effects of MMP-13 limit its application as a target enzyme of inhibitory drugs in the treatment of OA. 21 However, this does not apply to DDR2 because the activation of DDR2 by the interaction of the receptor with type II collagen occurs locally in the pericellular matrix of chondrocytes. We speculate that excessive mechanical force can incite chondrocytes to degrade the cartilaginous matrix through a process known as chondrocytic chondrolysis. As the degenerative process progresses over time, the activated chondrocytes synthesize and release matrix-degrading enzymes. As a consequence of enzyme release, there is disruption of the pericellular matrix of chondrocytes, which normally separates the surface of the chondrocytes from type II collagen fibrils present within the territorial and interterritorial locations of normal articular cartilage. Once the pericellular matrix is destroyed, chondrocytes are able to bind to type II collagen, which results in enhanced molecular signaling, mediated by DDR2. The activation of DDR2 then induces expression of MMP-13. Accordingly, interruption of the interaction of DDR2 with type II collagen by either small molecules or biological reagents can inhibit the activation of DDR2 to prevent induction of MMP-13. Third, one of the major concerns in the development of DMOADs is in regard to off-target effects of a drug. The next question becomes, if a small-molecular inhibitor of DDR2 is identified, which tissues can be affected by the inhibitor under normal physiological conditions? Results from the expression profile of Ddr2 in this study demonstrated that Ddr2 was not expressed broadly in adult mouse tissues. Expression was detected in the renal pelvis and testis of adult mice, which is consistent with the observation that males of homozygous knockout mice were infertile. 10 This information is of particular importance in the consideration of potential off-target effects of DDR2 inhibitors in adults, since such effects would be significantly limited because of the tissue-specific expression of DDR2. One study reports that the deletion of Ddr2 causes a defect of dermal wound healing associated with defective extracellular matrix remodeling. 26 Fourth, another interesting observation in this study is that articular cartilage could be protected by the conditional (local) removal of Ddr2 only in the articular cartilage of adult mouse knee joints. This suggests that intra-articular injections of a DDR2 inhibitor, or biological reagents that interrupt the interaction of DDR2 with type II collagen, could have an adequate protective effect on joints against the development of OA.
In the past 10 to 15 years, results from many independent research groups have demonstrated that the removal or inhibition of genes can protect articular cartilages from being degraded; such genes include a disintegrin and metalloproteinase with thrombospondin motifs 5 (Adamts-5), hypoxia-inducible factor-2a (HIF-2a), Wnt/b-catenin signaling, salt-inducible kinase 3 (Sik3), and the Zn importer ZIP8. The chondroprotective effect by the removal of Adamts-5 could in fact be because of the prevention of synovial fibrosis and stabilization of subchondral bone. 27, 28 It has been suggested that the deficiency of Hif-2a could possibly inhibit chondrocyte hypertrophy, resulting in the delay of articular cartilage degeneration in joints. 29 With regard to Wnt/b-catenin signaling, there is a report that the inhibition of b-catenin in chondrocytes results in OA in mice 30 ; however, results from another study indicate that the stabilization of b-catenin causes OA in mice. 31 The conflicting results may be because of the developmental-stage dependent manner of b-catenin function. Sik3 may play a role in regulation of homeostasis of articular cartilage, and the conditional removal of Sik3 from articular cartilage can protect knee joints against the development of OA in mice. 32 Data from a recent investigation demonstrate that the deletion of Zip8, a Zn 2þ importer, can delay the progression of OA induced by DMM. 33 Still, although the previously mentioned genes could be potential targets for the treatment of OA, further investigations are needed to determine the precise biological effects of these genes, or their down-stream molecules, on articular cartilages and other joint tissues if they are to be targets for the treatment of OA.
With regard to the development of novel therapeutic protocols to prevent healthy or degenerating joints from becoming OA joints, we may have to consider an approach to protect a whole joint, instead of targeting a particular joint tissue, such as articular cartilage or subchondral bone. 34 Results from the present study indicate that articular cartilage is still damaged continually without Ddr2 present in the cartilage. One possible reason is that different signaling pathways are involved in the induction of other extracellular matrix-degrading enzymes. Another plausible explanation is that the activation of Ddr2 in other joint tissues may also play a role in the destruction of articular cartilage. Data from several studies demonstrate DDR2 expression in bone tissue, 35, 36 and that DDR2 activation causes osteoblast differentiation, which, in turn, may affect the remodeling and stability of the subchondral bone. 37, 38 Another good example of a whole joint treatment approach is the role of transforming growth factor b1 signaling in the pathogenesis of OA. Results from our previous investigation indicated that the removal of Tgf-b1 signaling from mature articular cartilage could delay the degenerative progression of articular cartilage in mice. 16 Another independent research group reports that inhibition of Tgfb1 signaling in subchondral bone can protect articular cartilage from being degenerated. 39 Data from other studies demonstrate that an increase in the expression of Tgf-b1 signaling results in the hyperplasia of the synovial membrane and the damage of joint ligaments in mice. 40, 41 Clearly, it may be more effective to inhibit Tgf-b1 signaling in multiple joint tissues to protect the joint against the development of OA.
In summary, the results from the present investigation provide further information supporting that DDR2 is a potential target for the development of DMOADs.
